The Spring 2017 meeting was held at Syngenta, Jealott’s Hill, Berkshire on 26 April 2017.
Select the Title to access slides (where available)
Agenda
| Speaker | Time | Title |
| ***Registration*** | 08:30 | |
| ***Opening Remarks*** | 09:45 | |
| Stephanie Ashenden
University of Cambridge |
10:00 | Innovation in Small-Molecule-Druggable Chemical Space: Where are the Original Modulators of New Targets and New Bioactive Molecular Frameworks Published? A Comparison between Patents and Scientific Literature |
| Jack Scannell
UBS Investment Research |
10:30 | Damn the compass, full steam ahead: Decision theory and drug discovery |
| ***Coffee*** | 11:00 | |
| Matt Segall
Optibrium |
11:30 | Overcoming Psychological Barriers to Good Decision-Making in Drug Discovery |
| Paul Leeson
Paul Leeson Consulting Ltd. |
12:00 | Impact of Physicochemical Properties on Oral Drug Dose & Hepatotoxicity |
| ***Poster Flash Presentations*** | 12:30 | |
| ***Lunch*** | 12:45 | |
| Leen Kalash
University of Cambridge |
14:00 | Rational Design of Multi-target ligands at A1R, A2AR and PDE10A with Therapeutic Potential for Neurodegenerative Diseases |
| Josh Meyers
ICR |
14:30 | Mapping the 3D Structures of Small Molecule Binding Sites |
| ***Coffee*** | 15:00 | |
| Chris Radoux
CCDC |
15:30 | Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification |
| Joanna Zarnecka
Liverpool John Moores University |
16:00 | Optimization of shape fingerprints for protein-ligand systems |
| ***Final Remarks*** | 16:30 | |
| ***End*** | 16:45 |